Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$207.01 - $276.09 $1.45 Million - $1.93 Million
-7,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $1.02 Million - $1.21 Million
4,000 Added 133.33%
7,000 $1.91 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $1.58 Million - $2.07 Million
-7,000 Reduced 70.0%
3,000 $871,000
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $799,080 - $991,240
4,000 Added 66.67%
10,000 $2.38 Million
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $1 Million - $1.34 Million
6,000 New
6,000 $1.31 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $113B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.